Compression Feedback for Patients With In-hospital Cardiac Arrest

NCT02845011 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 900

Last updated 2018-07-06

No results posted yet for this study

Summary

A prospective, randomized, controlled, parallel study was conducted in patients undergoing resuscitation with chest compression for in-hospital cardiac arrest (IHCA) in the mixed medical-surgical ICU's of 8 academic tertiary care hospitals in Iran. Patients randomized into 2 groups: 1) standard chest compression, 2) chest compression with real-time audio-visual feedback using the Cardio First Angel™ (CFA; INOTECH, Nubberg, Germany) device. The primary outcome was sustained return of spontaneous circulation (ROSC). Secondary outcomes were survival to ICU and hospital discharge, incidence of sternum and rib fractures.

Conditions

  • Cardiopulmonary Arrest
  • Cardiopulmonary Resuscitation

Interventions

DEVICE

Audiovisual compression feedback

The Cardio First Angel™ (CFA; INOTECH, Nubberg, Germany) is a handheld device consisting of three components. The rescuer-side has a red palm-sized push-button with a pictogram illustrating proper use. The center unit is composed of a stable plastic base containing an arrangement of springs, and the patient-side consists of liquid-absorbent polyurethane foam. Application of 400 ± 30 Newtons of force results in an audible click alerting the rescuer to cease compression, and an additional click on decompression alerts the rescuer to resume compression.

OTHER

Standard Manual Chest Compression

Cardiopulmonary resuscitation according to published international guidelines.

Sponsors & Collaborators

  • Shahid Beheshti University

    collaborator OTHER
  • Tehran University of Medical Sciences

    collaborator OTHER
  • East Carolina University

    collaborator OTHER
  • Baqiyatallah Medical Sciences University

    lead OTHER

Principal Investigators

  • Amir Vahedian-azimi, PhD, RN · Baqiyatallah Universiy of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2015-09-15
Completion
2015-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02845011 on ClinicalTrials.gov